FDAnews
www.fdanews.com/articles/80738-intrac-changes-name-to-javelin-pharmaceuticals

INTRAC CHANGES NAME TO JAVELIN PHARMACEUTICALS

September 8, 2005

Today at its annual meeting of shareholders, Intrac, Inc. (OTC BB: ITRD) changed its name to Javelin Pharmaceuticals, Inc. as part of a reincorporation in the State of Delaware. Javelin common stock will trade under the symbol JVPH on the OTC Bulletin Board. The shareholders also elected the management slate of directors and ratified the Omnibus Stock Incentive Plan. This renaming reflects the array of pain management opportunities that the Company plans to pursue as it expands beyond its present boundaries. The new name took effect after receiving shareholder approval and completing regulatory filings. Intrac's wholly owned subsidiary, Innovative Drug Delivery Systems, Inc., is now a wholly owned subsidiary of Javelin.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050907006185&newsLang=en)